41. Thieme-connect / Seminars In Thrombosis And Hemostasis / Table Of Contents Seminars in thrombosis and Hemostasis Issue 03 Hemostasis and thrombosis inObstetrics and Gynecology Volume 31 June 2005. PREFACE http://www.thieme-connect.com/ejournals/toc/sth

Home Subject List Alphabetical List Help ... Deutsche Version Quick Search Advanced Search LogIn Username Password Register Now Free Trial Thieme-connect / Seminars in Thrombosis and Hemostasis / Table of contents Contact Us Seminars in Thrombosis and Hemostasis Issue 04 Reliability of Platelet Function Tests and Drug Monitoring Volume 31 August 2005 TUFTS UNIVERSITY SCHOOL OF MEDICINE OFFICE OF CONTINUING EDUCATION ACCREDITATION INFORMATION PDF (70 kb) Adverse Reactions to Anticoagulants and to Antiplatelet Drugs Recorded by the German Spontaneous Reporting System Full Text HTML (44 kb) PDF (399 kb) Jurk, Kerstin; Kehrel, Beate E.: Platelets: Physiology and Biochemistry Full Text HTML (72 kb) PDF (590 kb) Matzdorff, Axel: Platelet Function Tests and Flow Cytometry to Monitor Antiplatelet Therapy Full Text HTML (52 kb) PDF (119 kb) Klinkhardt, Ute; Harder, Sebastian: Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function? Full Text HTML (26 kb) PDF (106 kb) Haubelt, Hannelore; Anders, Christof; Hellstern, Peter: Can Platelet Function Tests Predict the Clinical Efficacy of Aspirin?

42. Aniara - Tests And Assays For Hemostasis And Thrombosis Distributor of biotechnology products for hemostasis, thrombosis, and autoimmunity diagnostic and research use. Provides company profile overview, product technical support and ordering information. http://aniara.com

Aniara ... The exploring company within hemostasis and thrombosis. Aniara launches Elisara Elisa Kits and Elitara Cardiovascular Assays in North American market. All Elisara and Elitara product orders placed by December 31, 2005, receive a 20% discount! Contact us for more information. ANIARA Corporation, in partnership with HYPHEN BioMed SA , an international leader in the field of hemostasis and thrombosis, offers a full line of diagnostic and research agents for thrombosis, hemostasis and autoimmunity to the North American and Nordic markets. Our goal and philosophy is to provide high-quality products in a cost-effective manner. Above all, we are fully devoted to exploring, developing and supporting new possibilities for innovative and improved diagnostic means in the hemostasis and thrombosis field. In support of this, we offer a 25% discount on our products to academic researchers. Aniara/Hyphen BioMed is looking forward to seeing you at ASH 2005 in New Orleans. Please stop by our booth (#759) and discover the future of Coagulation/Hematology. ANIARA Corporation is committed to the continual process of research in the thrombosis and hemostasis field. Qualifying academic researches who join our Research Value Program will receive a

43. The National Alliance For Thrombosis & Thrombophilia Includes organization background, events, and links to further information. http://www.nattinfo.org/

Read the Welcome to The National Alliance for Thrombosis and Thrombophilia (NATT) The National Alliance for Thrombosis and Thrombophilia (NATT) is a nationwide, community-based, volunteer health organization formed in August 2003. Committed to preventing and treating the array of major health problems caused by blood clots, NATT’s charter members were visionary patients attending a thrombosis and thrombophilia awareness meeting at the Centers for Disease Control and Prevention. Today, NATT’s membership and influence is growing. With the goal to ensure that people suffering from thrombosis and thrombophilia get early diagnosis, optimal treatment, and quality support, NATT members are committed to fostering research, education, support, and advocacy on behalf of those at risk of, or affected by, blood clots. Click here to download our Spring 2005 newsletter!! A primary goal of NATT is to provide education and information to individuals and families affected by blood clots and blood clotting disorders. NATT is currently working on developing it’s own materials to address these topics. In the meantime, members of the Education Committee have identified and reviewed published materials in various subject areas, which we hope are relevant to you. - Start learning right now!

44. SpringerLink - Publication www.kluweronline.com/issn/09295305 Elsevier.com - thrombosis Researchthrombosis Research Vascular Obstruction, Hemorrhage and Hemostasis thrombosis Research is an international journal with a goal of rapid dissemination http://www.kluweronline.com/issn/0929-5305/contents

Articles Publications Publishers Home Publication Journal of Thrombosis and Thrombolysis Publisher: Springer Science+Business Media B.V., Formerly Kluwer Academic Publishers B.V. ISSN: 0929-5305 (Paper) 1573-742X (Online) Subject: Medicine Issues in bold contain content you are entitled to view. Volume 20 Number 1 / August 2005 Volume 19 Number 3 / June 2005 Number 2 / April 2005 Number 1 / February 2005 Request a sample Volume 18 Number 3 / December 2004 Number 2 / October 2004 Number 1 / August 2004 Volume 17 Number 3 / June 2004 Number 2 / April 2004 Number 1 / February 2004 Title: Special Issue on Vascular Disease: Contemporary Thoughts on the Disease and the Management Strategies Volume 16 Number 3 / December 2003 Numbers 1-2 / August 2003 Volume 15 Number 3 / June 2003 Number 2 / April 2003 Number 1 / February 2003 Volume 14 Number 3 / December 2002 Number 2 / October 2002 Number 1 / August 2002 Volume 13 Number 3 / June 2002 Number 2 / April 2002 Number 1 / February 2002 Volume 12 Number 3 / December 2001 Number 2 / October 2001 Number 1 / September 2001 Volume 11 Number 3 / May 2001 Number 2 / April 2001 Number 1 / February 2001 Volume 10 Number 3 / December 2000 Number 2 / October 2000 Number 1 / August 2000 Supplement 1 / November 2000 Volume 9 Number 3 / April 2000 Number 2 / February 2000 Number 1 / January 2000 Supplement 1 / June 2000 Volume 8 Number 3 / October 1999 Number 2 / August 1999 Number 1 / July 1999 Volume 7 Number 3 / June 1999 Number 2 / April 1999 Number 1 / January 1999 Volume 6

45. ConjuChem Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview, research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada. http://www.conjuchem.com/

46. Journal Of Thrombosis And Haemostasis Home Page Journal of thrombosis and Haemostasis; journal information, contents lists andabstracts on the Blackwell Publishing webstite. http://www.blackwellpublishing.com/journal.asp?ref=1538-7933

47. Innohep Tinzaparin sodium. Features product information as well as descriptions of deep vein thrombosis and pulmonary embolisms. http://www.innohep.com

var ReplicaId="/C1256CE8005847F4/"; var docID="F49A55A6BA750F66C1256D8000426E3B"; var docForm = "docLoginform"; var HRrepID="C1256B8800458DF4"; var repID="/C1256CE8005847F4/"; var homeUrl="/w-site/innohep/docs.nsf/"; var varLoginWarning="You will now be redirected to the website frontpage. Please log in using the login area found here."; var varREADMORE="Read more"; var varConfRepId="C1256CE8005876D1"; var varLang="UK"; var varSiteInfo="www.innohep.com"; var varkwlLastMessage=""; var varSessionUser="Anonymous"; Login for non-US residents E-mail address: Password: Have you forgotten your password? Having problems logging on? New user? (Non-US residents only) Register here This site is for healthcare professionals only US residents For more information on innohep ® please send an e-mail to: innohep@leo-pharma.com

48. Biological Methods Of Therapy Program Alternative Program for latestage and non-responsive diseases. The Clinic provides an alternative means of curing many serious diseases including some that stymie modern conventional medicine such as; inoperable cancer and paralysis caused by severe cerbral thrombosis. http://www.ournet.md/~bmtp

Biological Methods of Therapy Program. We, at the Biological Therapy Clinic, provide an effective alternative means of curing many serious diseases including some that stymie modern conventional medicine such as; inoperable cancer and paralysis caused by severe cerbral thrombosis. We use a holistic approach over a period of approximately one to two months that includes: Biological energy therapy to restore the body's energy balance to its pre-injured state. Nutritional therapy based on dietary changes to restore the body's immune system. Colon therapy to clear out the body's accumulated poisons. Our core medical staff, who are all citizens of Moldova, consist of a specialist-healer, a body energy information analyst and an assistant. To assist our foreign patients we also provide the services of interpreters who are fluent in various foreign languages. Our staff is in a position to attend to the needs of our patients in the comfort of their own homes where ever that might be, although the cost of their travel, accommodation and meals must be born by the patient, with payment made in advance. Despite the inconvenience we recommend whenever possible that patients attend our clinic in Chisinau, Moldova. This will allow us to ensure the best results possible and the most trouble-free treatment. In the event of travel to our clinic, patients will be met at Chisinau International airport and we will take care of all entrance formalities for them, their attending physician(s) if that is required, and accompanying family members, and will arrange for transportation and accommodation at one of Chisinau's 4 star Western European class hotels.

49. Thrombosis And Haemostasis Editorial Board Subscriptions Advertising (Media Kit) Impressum / About us www.schattauer.com. Search thrombosis and Haemostasis for http://www.thrombosis-online.com/

Thrombosis and Haemostasis Current Issue Archive TH First Contact ... Instructions to Authors Volume 93/6, June 2005 Editorial Board Subscriptions Advertising (Media Kit) Impressum / About us ... www.schattauer.com Search Thrombosis and Haemostasis for: Help

50. Cardiovascular Medicine - UMass Medical School Has research programs in prevention and behavior, epidemiology, thrombosis, interventional technique, atherosclerosis, cardiac arrhythmias, gene therapy and nuclear cardiology. http://www.umassmed.edu/cardio/

directory contacts index this section only Cardiovascular Homepage Faculty Fellowship Program Cardiovascular Services ... cardiovascular medicine Welcome to the Division of Cardiovascular Medicine The Division of Cardiovascular Medicine has research programs in prevention and behavior epidemiology thrombosis interventional technique atherosclerosis cardiac arrhythmias gene therapy and nuclear cardiology. The Division has been involved in numerous NIH-sponsored research trials and studies including Thrombolysis in Myocardial Infarction (TIMI) Bypass Angioplasty Revascularization Investigation (BARI) Cardiac Arrhythmia Suppression Trial (CAST) Rapid Early Action for Coronary Treatment (REACT) Multicenter Unsustained Tachycardia Trial (MUSTT) Mode Selection for Sinus Node Dysfunction (MOST) and Worcester Area Trials for Cholesterol and Hyperlipidemia (WATCH). National Institutes of Health American Heart Association and non-federal sources. INTRANET top print This is an official Page/Publication of the University of Massachusetts Worcester Campus Cardiovascular Medicine 55 Lake Avenue North Worcester, MA 01605

51. Welcome To NHS Direct Online thrombosis means the clotting of blood within an artery or a vein. When thrombosisaffects important arteries, such as the coronary arteries (causing a http://www.nhsdirect.nhs.uk/en.asp?TopicID=447

52. CNN.com - Health - Airlines Urged To Issue Health Warnings - November 22, 2000 CNN http://cnn.com/2000/HEALTH/11/22/airtravel.thrombosis/index.html

health Editions myCNN Video ... Feedback CNN Sites CNN CNN Europe CNNfn CNNSI myCNN CNNfyi AllPolitics Languages Search CNN.com CNNSI.com CNNfn.com The Web HEALTH TOP STORIES New treatments hold out hope for breast cancer patients MORE TOP STORIES Thousands dead in India; quake toll rapidly rising Israelis, Palestinians make final push before Israeli election Davos protesters confront police MORE ... MORE MARKETS 4:30pm ET, 4/16 DJIA NAS SPORTS Jordan says farewell for the third time ... LOCAL EDITIONS: CNN.com Europe change default edition MULTIMEDIA: video video archive audio multimedia showcase ... more services E-MAIL: Subscribe to one of our news e-mail lists Enter your address: DISCUSSION: chat feedback CNN WEB SITES: CNNfyi.com CNN.com Europe AsiaNow Spanish ... Korean Headlines TIME INC. SITES: Go To ... Time.com People Money Fortune EW CNN NETWORKS: CNN anchors transcripts Turner distribution SITE INFO: help contents search ad info ... jobs WEB SERVICES: Airlines urged to issue health warnings LONDON, England Airlines have been told they should issue health warnings with their tickets to inform passengers of the dangers of a potentially fatal condition which could strike during flights. The recommendation from a British parliamentary committee comes amid growing concerns over deep vein thrombosis (DVT), also known as "economy class syndrome", after a woman died from the condition after a long haul flight.

53. Welcome To NHS Direct Online The word ‘thrombosis’ means clotting of blood within an artery or a vein. A deepvein thrombosis (DVT) is a clot occurring in the large veins of the legs http://www.nhsdirect.nhs.uk/en.asp?TopicID=148

54. UCSF Hemostasis And Thrombosis Center: Main Menu Features information about current research studies such as ELATE and PREVENT, anticogulation and antithrombotic medications, treatment and testing, hypercoagulability factors, and detailed information for patients. http://medicine.ucsf.edu/htc/

Our Mission Research Information for Clinics Medications Patient Information Contact Us Department of Medicine Division of Hematology/Oncology Director, Patrick Fogarty, MD

55. Deep Vein Thrombosis - Heart Disease And Other Cardiovascular Conditions On Medi Information on heart disease and related cardiovascular conditions includesmedications, procedures and tests, symptoms, and treatment. http://www.medicinenet.com/deep_vein_thrombosis/article.htm

document.writeln(''); MedicineNet Home Heart Home Page > Deep Vein Thrombosis Search Tips Printer-Friendly Format FREE Newsletters Email to a Friend ... Next Deep Vein Thrombosis and Pulmonary Embolism What is a deep vein thrombosis (DVT) and a pulmonary embolism? What causes a DVT? What are the symptoms of a DVT or a pulmonary embolism? How is a DVT diagnosed? ... Deep Vein Thrombosis At A Glance What is a deep vein thrombosis and a pulmonary embolism? A vein is a blood vessel that returns blood from the tissues of the body back to the heart. The body has two distinct systems of veins, a superficial system and a deep system. The superficial system is made up of veins that are close to the skin. These are the blood vessels you frequently can see on your hand or arms and which become more prominent when you exercise. The deep system is comprised of veins within the muscles of the body. The two systems are connected by small communicating veins. The body regulates the amount of blood going through both systems as a way of rigidly controlling the body's central temperature. (More heat is lost when blood flows through the superficial than the deep system.) A DVT is a condition wherein a blood clot (thrombus) forms in a vein of the deep system. Thrombophlebitis is a condition in which there is both inflammation and a blood clot in a vein. Thrombophlebitis can occur in either superficial or deep veins. Superficial thrombophlebitis occurs in veins close to the skin surface, and usually causes pain, swelling, and redness in the area of the vein. Superficial thrombophlebitis usually is treated with heat, elevation of the affected leg or arm, and anti-inflammatory medications. A thrombosis in a deep vein is a much more serious problem than one in a superficial vein. The reason for this is that a piece of the clot in DVT may break off and travel through the deep veins back to the heart, and eventually be pumped by the heart into the arteries of the lung. When this happens, the condition is called pulmonary embolism. The blood clot is called an embolus (for which the plural is emboli), and the process of breaking off and traveling to the lungs is called embolism.

56. Genomics|Population Research|Health Studies|Protein C And Venous Thrombosis Center for Disease Control's page discussing the background of this disorder including study results, testing, and complications. http://www.cdc.gov/genomics/info/reports/research/protein_c.html

home population research health studies Archived: Aug 1998 Journal Publication This review was published with modifications in Am J Med Sci. 1998 Aug; 316(2): 120-128 The Role of Activated Protein C Resistance in the Pathogenesis of Venous Thrombosis by W. Craig Hooper and Bruce L. Evatt Introduction Pathophysiology APC-R and Factor V Leiden: Clinical Features FV Leiden in Women ... References Introduction Following myocardial infarction and stroke, venous thromboembolism (VTE) is the third most common cardiovascular disease in the United States. The mortality and morbidity of VTE is significant with an annual incidence of approximately 1:1000 individuals and pulmonary embolism is a leading cause of in-patient hospital deaths (1,2). It has been estimated that venous thrombosis is responsible for between 300,000-600,000 hospitalizations and up to 100,000 deaths annually (3,4). The clinical consequences of venous thrombosis such as chronic venous insufficiency with skin ulceration affects up to 500,000 individuals per year. Studies have reported that as many as 90% of patients with venous thrombosis suffer significant disabilities at 2-5 year follow-up intervals (5). The current health costs associated with VTE are significant and are expected to rise as the prevalence of VTE increases in the aging population (6,7). The purpose of this review is to briefly re-acquaint the reader with the pathobiology of the anticoagulant protein system and to review the clinical implications of APC-R.

57. Holiday Travel: Avoiding Deep Vein Thrombosis DVT - Healthy Living Overview: Die Healthy Living Index provides info on healthy diet, fitness, emotional wellness,nutrition, relationship, prevention. http://www.medicinenet.com/script/main/art.asp?articlekey=40582

58. NEJM -- Cerebral Sinovenous Thrombosis In Children Original article from The New England Journal of Medicine presents a study into the causes and effects of blood clots in the neonatal brain. Free registration required for full text. http://content.nejm.org/cgi/content/abstract/345/6/417

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Previous Volume 345:417-423 August 9, 2001 Number 6 Next Cerebral Sinovenous Thrombosis in Children Gabrielle deVeber, M.D., Maureen Andrew, M.D., Coleen Adams, M.B., Bruce Bjornson, M.D., Frances Booth, M.D., David J. Buckley, M.B., Ch.B., Carol S. Camfield, M.D., Michele David, M.D., Peter Humphreys, M.D., Pierre Langevin, M.D., E. Athen MacDonald, M.D., Brandon Meaney, M.D., Michael Shevell, M.D., C.M., D. Barry Sinclair, M.D., Jerome Yager, M.D., Jane Gillett, M.D., for the Canadian Pediatric Ischemic Stroke Study Group Full Text PDF Add to Personal Archive Add to Citation Manager ... PubMed Citation ABSTRACT Background Cerebral sinovenous thrombosis in children is a serious disorder, and information is needed about its prevention and treatment. Methods The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. Children (newborn to 18 years of age) with symptoms and radiographic confirmation of sinovenous thrombosis were included.

59. EMedicine - Deep Venous Thrombosis And Thrombophlebitis : Article By Donald Schr Deep Venous thrombosis and Thrombophlebitis Deep venous thrombosis (DVT) andits sequela, pulmonary embolism, are the leading causes of preventable http://www.emedicine.com/emerg/topic122.htm

(advertisement) Home Specialties Resource Centers CME ... Patient Education Articles Images CME Patient Education Advanced Search Consumer Health Link to this site Back to: eMedicine Specialties Emergency Medicine Cardiovascular Deep Venous Thrombosis and Thrombophlebitis Last Updated: March 2, 2005 Rate this Article Email to a Colleague Synonyms and related keywords: DVT, deep vein thrombosis deep-vein thrombosis deep vein thrombi venous thrombosis ... lower extremity DVT , deep vein blood clots, deep-vein blood clots, pulmonary embolism PE , deep venous thrombophlebitis, deep vein thrombophlebitis, deep-vein thrombophlebitis superficial vein thrombophlebitis superficial-vein thrombophlebitis superficial thrombophlebitis , heparin, low-molecular-weight-heparin, LMWH, Virchow triad, venous stasis , vessel wall injury, hypercoagulable state, calf vein DVT isolated calf vein DVT peripheral venous disease varicose veins , catheter-induced DVT, calf vein thrombi chronic venous insufficiency venous ulceration phlegmasia cerulea dolens ... phlegmasia alba dolens , long plane trips, long car trips, acute myocardial infarction , immobilization longer than 3 days, stroke systemic lupus erythematosus SLE Behçet syndrome ... protein S deficiency , factor V Leyden, dysfibrinogenemias disorders of plasminogen activation IV drug abuse oral contraceptives , estrogens, heparin-induced thrombocytopenia, Wells Clinical Score for DVT AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials ... Bibliography Author:

60. Clinical And Research Laboratories -- Florida Hospital Cancer Institute Clinical testing and research in hemostasis, thrombosis and cancer. Details of research programs, publications and lectures are provided as well as information on services offered. http://www.fhci-labs.com/researchlabs/

new ypChaser("menuPositioner", 0, 1200, 0, 0) Welcome The Clinical and Research Laboratories of the Florida Hospital Cancer Institute were founded in 1994. Now known as the Florida Hospital Institute of Translational Research, this unique facility combines advanced clinical testing services with cutting edge research in the areas of hemostasis, thrombosis and cancer. This Internet site provides a lot of information about our programs Mission - why we do what we do Check out What's New? for the latest from our labs Meet our Staff or check out Employment Opportunities in our laboratory Ge t more details on our Research Programs and their significance View our Publications and Presentations to see what we are publishing or presenting at scientific meetings The lists of Lectures and Reviews will tell you what we have been asked to talk and write about Visit our clinical laboratories - the Hemostasis and Thrombosis Laboratory - specialty testing for bleeding and clotting disorders; the

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 139    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | Next 20